Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Alout, Haoues ^a   Krajacich, Benjamin J ^a   Meyers, Jacob I ^a   Grubaugh, Nathan D ^a   Brackney, Doug E ^a   Kobylinski, Kevin C ^b,c   Diclaro, Joseph W ^d   Bolay, Fatorma K ^e   Fakoli, Lawrence S ^e   Diabaté, Abdoulaye ^f   Dabiré, Roch K ^f   Bougma, Roland W ^g   Foy, Brian D ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d US Naval Medical Research Unit No 3 Egypt   (Egypt)

^e Liberia Institute for Biomedical Research   (Liberia)

^f Institut de Recherche en Sciences de la Santé   (Burkina Faso)

^g MINISTÈRE DE LA SANTÉ   (Burkina Faso)

Author keywords

Anopheles gambiae; Environment; Ivermectin; Malaria control; Mass drug administration; Parity; Plasmodium falciparum; Survival; Transmission; West Africa

Indexed keywords

ALBENDAZOLE; IVERMECTIN; ANTIMALARIAL AGENT; INSECTICIDE;

ANOPHELES GAMBIAE; ARTICLE; BURKINA FASO; BURKINABE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; HEALTH CARE DISTRIBUTION; HOST PARASITE INTERACTION; HUMAN; LIBERIA; LIBERIAN; LYMPHATIC FILARIASIS; MALARIA; MALARIA CONTROL; MASS DRUG ADMINISTRATION; MORTALITY; NONHUMAN; ONCHOCERCIASIS; PARASITE SURVIVAL; PARITY; PHARMACEUTICAL CARE; PLASMODIUM; PREVENTIVE HEALTH SERVICE; SEASONAL VARIATION; SENEGAL; SENEGALESE; SPOROZOITE; TROPICAL DISEASE; WEST AFRICAN; AFRICA; ANIMAL; DRUG EFFECTS; PHYSIOLOGY; TRANSMISSION;

AFRICA, WESTERN; ANIMALS; ANOPHELES GAMBIAE; ANTIMALARIALS; FEMALE; HUMANS; INSECTICIDES; IVERMECTIN; MALARIA; PARITY; PLASMODIUM; SPOROZOITES;

EID: 84920837068     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-417     Document Type: Article

References (31)

1. WHO: World Malaria Report. Geneva: World Health Organization; 2013.
2. Pluess B, Tanser FC, Lengeler C, Sharp BL: Indoor residual spraying for preventing malaria. Cochrane Database Syst Rev 2010, 4:CD006657.
3. Ranson H, N'Guessan R, Lines J, Moiroux N, Nkuni Z, Corbel V: Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control? Trends Parasitol 2011, 27:91-98.
4. Trape J-F, Tall A, Diagne N, Ndiath O, Ly AB, Faye J, Dieye-Ba F, Roucher C, Bouganali C, Badiane A, Sarr FD, Mazenot C, Touré-Baldé A, Raoult D, Druilhe P, Mercereau-Puijalon O, Rogier C, Sokhna C: Malaria morbidity and pyrethroid resistance after the introduction of insecticide-Treated bednets and artemisinin-based combination therapies: A longitudinal study. Lancet 2011, 11:925-932.
5. Mita T, Tanabe K: Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance. Jpn J Infect Dis 2012, 65:465-475.
6. The malERA Consultative Group on Vector Control: A research agenda for malaria eradication: vector control. PLoS Med 2011, 8:e1000401.
7. Mectizan Donation Program: Mectizan Annual Highligths; 2013.
8. Chaccour CJ, Kobylinski KC, Bassat Q, Bousema T, Drakeley C, Alonso P, Foy BD: Ivermectin to reduce malaria transmission: A research agenda for a promising new tool for elimination. Malar J 2013, 12:153.
9. Bockarie MJ, Hii JL, Alexander N, Bockarie F, Dagoro H, Kazura JW, Alpers MP: Mass treatment with ivermectin for filariasis control in Papua New Guinea: impact on mosquito survival. Med Vet Entomol 1999, 13:120-123.
10. Sylla M, Kobylinski KC, Gray M, Chapman PL, Sarr MD, Rasgon JL, Foy BD: Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors. Malar J 2010, 9:365.
11. Foy BD, Kobylinski KC, da Silva IM, Rasgon JL, Sylla M: Endectocides for malaria control. Trends Parasitol 2011, 27:423-428.
12. Kobylinski KC, Sylla M, Chapman PL, Sarr MD, Foy BD: Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages. Am J Trop Med Hyg 2011, 85:3-5.
13. Gething PW, Patil AP, Smith DL, Guerra C a, Elyazar IRF, Johnston GL, Tatem AJ, Hay SI: A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J 2011, 10:378.
14. Krajacich BJ, Slade JR, Mulligan RF, LaBrecque B, Alout H, Grubaugh ND, Meyers JI, Fakoli LS, Bolay FK, Brackney DE, Burton TA, Seaman JA, Sylla M, Diclaro JW II, Dabiré RK, Foy BD: Sampling host-seeking anthropophilic mosquito vectors in West Africa: comparisons of an active human-baited tent-Trap against gold standard methods. Am J Trop Med Hyg. In press.
15. Detinova TS: Age-grouping methods in Diptera of medical importance with special reference to some vectors of malaria. Monogr Ser World Health Organ 1962, 47:13-191.
16. Fanello C, Santolamazza F, della Torre A: Simultaneous identification of species and molecular forms of the Anopheles gambiae complex by PCRRFLP. Med Vet Entomol 2002, 16:461-464.
17. Bass C, Nikou D, Blagborough AM, Vontas J, Sinden RE, Williamson MS, Field LM: PCR-based detection of Plasmodium in Anopheles mosquitoes: A comparison of a new high-Throughput assay with existing methods. Malar J 2008, 7:177.
18. Kobylinski KC, Deus KM, Butters MP, Hongyu T, Gray M, da Silva IM, Sylla M, Foy BD: The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors. Acta Trop 2010, 116:119-126.
19. Koella JC: On the use of mathematical models of malaria transmission. Acta Trop 1991, 49:1-25.
20. Slater HC, Walker PGT, Bousema T, Okell LC, Ghani AC: The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: A modelling study. J Infect Dis 2014:jiu351.
21. Awadzi K, Edwards G, Duke BOL, Opoku NO, Attah SK, Addy ET, Ardrey AE, Quartey BT: The co-Administration of ivermectin and albendazole: safety, pharmacokinetics and efficacy against Onchocerca volvulus. Ann Trop Med Parasitol 2003, 97:165-178.
22. Garrett-Jones C: The assessment of insecticidal impact on the malaria mosquito's vectorial capacity, from data on the proportion of parous females. Bull World Health Organ 1964, 31:71-86.
23. Rajatileka S, Burhani J, Ranson H: Mosquito age and susceptibility to insecticides. Trans R Soc Trop Med Hyg 2011, 105:247-253.
24. Kobylinski KC, Foy BD, Richardson JH: Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae. Malar J 2012, 11:381.
25. Fritz ML, Siegert PY, Walker ED, Bayoh MNI, Vulule JRI: Toxicity of bloodmeals from ivermectin-Treated cattle to Anopheles gambiae s.l. Ann Trop Med Parasitol 2009, 103:539-547.
26. Kamgno J, Gardon J, Gardon-Wendel N, Demanga-Ngangue, Duke BOL, Boussinesq M: Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or threemonthly. Trans R Soc Trop Med Hyg 2004, 98:496-504.
27. Heukelbach J, Winter B, Wikcke T, Muehlen M, Albrecht S, de Oliveira FA S, Sansigolo Kerr-Pontes LR, Liesenfeld O, Feldmeier H: Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bull World Health Organ 2004, 82:563-571.
28. Mueller I, Schoepflin S, Smith TA, Benton KL, Bretscher MT, Lin E, Kiniboro B, Zimmerman PA, Speed TP, Siba P, Felger I: Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children. Proc Natl Acad Sci U S A 2012, 109:10030-10035.
29. Kobylinski K, Alout H, Foy BD, Clements A, Adisakwattana P, Swierczewski B, Richardson J: Rationale for the co-Administration of albendazole and ivermectin to humans for malaria parasite transmission control. Am J Trop Med Hyg 2014, 91:655-662.
30. Remme J, The CDI study group: Community-directed interventions for priority health problems in Africa: results of a multicountry study. Bull World Health Organ 2010, 88:509-518.
31. Blackburn BG, Eigege A, Gotau H, Gerlong G, Miri E, Hawley W a, Mathieu E, Richards F: Successful integration of insecticide-Treated bed net distribution with mass drug administration in Central Nigeria. Am J Trop Med Hyg 2006, 75:650-655.